AJCN EB Program 2010 Early Registration
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mitea, C.
Right arrow Articles by Dekking, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mitea, C.
Right arrow Articles by Dekking, L.
Agricola
Right arrow Articles by Mitea, C.
Right arrow Articles by Dekking, L.
American Journal of Clinical Nutrition, Vol. 88, No. 4, 1057-1066, October 2008
© 2008 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Fine specificity of monoclonal antibodies against celiac disease–inducing peptides in the gluteome1,2,3

Cristina Mitea, Yvonne Kooy-Winkelaar, Peter van Veelen, Arnoud de Ru, Jan W Drijfhout, Frits Koning and Liesbeth Dekking

1 From the Department of Blood Transfusion and Immunohematology, Leiden University Medical Center, Leiden, Netherlands(CM, YK-W, PvV, AdR, JWD, FK, and LD), and the Center for Medical Systems Biology, Leiden University Medical Center, Leiden, Netherlands (PvV and AdR)

Background: In celiac disease patients, peptides derived from dietary gluten are recognized by HLA-DQ2-restricted CD4+ T cells, which results in inflammation. Such immune-stimulatory peptides are found in both gliadins and glutenins. Monoclonal antibodies (mAbs) against these peptides can be used to screen food for the presence of such peptides.

Objective: We aimed to determine the specificity of 5 mAbs raised against T cell stimulatory peptides found in {alpha}- and {gamma}-gliadins and in low- and high-molecular-weight glutenins and to compare it with the specificity of patient-derived T cells.

Design: The reactivity of the mAbs with gluten peptides, enzymatic gluten digests, and intact gluten proteins was determined and compared with that of gluten-specific T cells by using a combination of immunologic and biochemical techniques. Furthermore, the reactivity of the mAbs with gluten homologues in barley, rye, and oat was determined.

Results: The specificity of the mAbs largely overlaps with that of gluten-specific T cells. Moreover, mAbs detect several homologous peptides present in gluten proteins. All except the LMW-specific mAbs also detect storage proteins present in barley and rye, whereas the {gamma}-gliadin-specific mAbs also recognize oat proteins.

Conclusion: The mAbs raised against T cell stimulatory peptides in gliadins and glutenins allow a comprehensive screen for the presence of harmful gluten and gluten-like proteins and peptides in food products. They can thus be used to guarantee the safety of food for celiac disease patients.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The American Society for Nutrition